As of May 05, 2025, COMPASS Pathways (CMPS) has a market cap of $0.35 billion USD. According to our data, COMPASS Pathways is ranked No.6404 in global market value.
Year | Market Cap | %Change |
---|---|---|
May 05, 2025 | $0.35 B |
35.09%
|
Dec 31, 2024 | $0.26 B |
-56.80%
|
Dec 29, 2023 | $0.60 B |
8.97%
|
Dec 30, 2022 | $0.55 B |
-63.67%
|
Dec 31, 2021 | $1.51 B |
-53.61%
|
Dec 31, 2020 | $3.26 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Mind Medicine
MNMD
|
$0.48 B |
0.000 M
|
![]() USA
|
![]() Atai Life Sciences
ATAI
|
$0.28 B |
-0.000 M
|
![]() Germany
|
![]() Cybin
CYBN
|
$0.15 B |
3.197 M
|
![]() Canada
|
![]() GH Research
GHRS
|
$0.56 B |
0.000 M
|
![]() Ireland
|
![]() Seelos Therapeutics
SEEL
|
$0.21 M |
0.023 M
|
![]() USA
|
Market Cap | = | CMPS Stock Price | * | CMPS Shares Outstanding |
= | $3.77 | * | 92.67 M | |
= | $0.35 B |